Vaxart (VXRT) Competitors

CryoPort (NASDAQ:CYRX) and Vaxart (NASDAQ:VXRT) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

Do institutionals & insiders believe in CYRX or VXRT?

92.9% of CryoPort shares are owned by institutional investors. Comparatively, 18.0% of Vaxart shares are owned by institutional investors. 10.1% of CryoPort shares are owned by company insiders. Comparatively, 2.9% of Vaxart shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the media refer more to CYRX or VXRT?

In the previous week, CryoPort and CryoPort both had 3 articles in the media. Vaxart's average media sentiment score of 1.06 beat CryoPort's score of 0.57 indicating that Vaxart is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CryoPort	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Vaxart	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, CYRX or VXRT?

CryoPort has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500. Comparatively, Vaxart has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.

Do analysts recommend CYRX or VXRT?

CryoPort presently has a consensus target price of $10.88, indicating a potential upside of 47.08%. Vaxart has a consensus target price of $3.00, indicating a potential upside of 695.76%. Given Vaxart's stronger consensus rating and higher possible upside, analysts plainly believe Vaxart is more favorable than CryoPort.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CryoPort	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75
Vaxart	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has stronger valuation & earnings, CYRX or VXRT?

Vaxart has lower revenue, but higher earnings than CryoPort. CryoPort is trading at a lower price-to-earnings ratio than Vaxart, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CryoPort	$228.38M	1.62	-$114.76M	-$2.34	-3.16
Vaxart	$47.40M	1.82	-$66.95M	-$0.27	-1.40

Is CYRX or VXRT more profitable?

CryoPort has a net margin of -50.15% compared to Vaxart's net margin of -122.63%. CryoPort's return on equity of -11.03% beat Vaxart's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CryoPort	-50.15%	-11.03%	-5.54%
Vaxart	-122.63%	-91.89%	-38.40%

Summary

CryoPort beats Vaxart on 8 of the 15 factors compared between the two stocks.